Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Senti Bio Participates in a Virtual Investor KOL Connect Segment
Posted On Monday, April 21, 2025
PathAI Announces Poster Presentations at the 2025 American Association of Cancer Research Annual Meeting
Posted On Monday, April 21, 2025
Eascra Biotech Receives U.S. National Science Foundation Grant
Posted On Monday, April 21, 2025
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab’s Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)
Posted On Monday, April 21, 2025
IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting
Posted On Monday, April 21, 2025
Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences
Posted On Monday, April 21, 2025
Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings
Posted On Monday, April 21, 2025
Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
Posted On Monday, April 21, 2025
BioStem Technologies to Present at the Centri Capital Conference
Posted On Monday, April 21, 2025
Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
Posted On Monday, April 21, 2025
Apellis Announces Craig Wheeler to Join the Board of Directors
Posted On Monday, April 21, 2025
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines
Posted On Monday, April 21, 2025
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
Posted On Monday, April 21, 2025
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
Posted On Monday, April 21, 2025
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
Posted On Monday, April 21, 2025
BioCryst to Report First Quarter 2025 Financial Results on May 5
Posted On Monday, April 21, 2025
Alumis and ACELYRIN Announce Amended Merger Agreement
Posted On Monday, April 21, 2025
Boston Hemp Launches New Line of Premium THCa Concentrates
Posted On Sunday, April 20, 2025
23andMe Provides Update Regarding Court-Supervised Sale Process
Posted On Friday, April 18, 2025
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application
Posted On Friday, April 18, 2025
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Posted On Friday, April 18, 2025
Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025
Posted On Friday, April 18, 2025
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Posted On Thursday, April 17, 2025
INVESTOR ALERT: Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors with Significant Losses to Consider Leading Litigation
Posted On Thursday, April 17, 2025
Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders
Posted On Thursday, April 17, 2025

Print